dalteparin has been researched along with Cataract in 4 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Cataract: Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Masked postoperative examinations assessed visual acuity, intraocular pressure (IOP), anterior chamber cell and flare, and fibrin formation with slitlamp examinations 1, 3, 7, 30, and 90 days after surgery." | 5.12 | Inhibition of intraocular fibrin formation after infusion of low-molecular-weight heparin during combined phacoemulsification-trabeculectomy surgery. ( Abdollahi, A; Amini, H; Azimi, R; Eslami, Y; Fakhraii, G; Moghimi, S; Zarei, R, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ilhan, O | 1 |
| Ilhan, N | 1 |
| Coşkun, M | 1 |
| Dağlioğlu, MC | 1 |
| Ayhan Tuzcu, E | 1 |
| Ayintap, E | 1 |
| Keskın, U | 1 |
| Oksüz, H | 1 |
| Rumelt, S | 1 |
| Stolovich, C | 1 |
| Segal, ZI | 1 |
| Rehany, U | 1 |
| Wilson, ME | 1 |
| Trivedi, RH | 1 |
| Zarei, R | 1 |
| Azimi, R | 1 |
| Moghimi, S | 1 |
| Abdollahi, A | 1 |
| Amini, H | 1 |
| Eslami, Y | 1 |
| Fakhraii, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized Clinical Trial Evaluating Anti-inflammatory Effect of Low Molecular-Weight Heparin in Pediatric Cataract and Intraocular Lens Surgery[NCT00986076] | Phase 4 | 23 participants (Actual) | Interventional | 2008-03-31 | Completed | ||
| Comparison of Combined Phacotrabeculectomy and Trabeculectomy Only in the Treatment of Primary Angle-closure Glaucoma[NCT01298635] | 31 participants (Actual) | Interventional | 2005-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for dalteparin and Cataract
| Article | Year |
|---|---|
The effect of enoxaparin-containing irrigation fluid used during cataract surgery on postoperative inflammation in patients with diabetes.
Topics: Aged; Anterior Chamber; Anticoagulants; Cataract; Cataract Extraction; Diabetes Mellitus; Diabetic R | 2013 |
Inhibition of intraocular fibrin formation after infusion of low-molecular-weight heparin during combined phacoemulsification-trabeculectomy surgery.
Topics: Aged; Cataract; Dalteparin; Double-Blind Method; Female; Fibrin; Fibrinolytic Agents; Glaucoma; Huma | 2006 |
2 other studies available for dalteparin and Cataract
| Article | Year |
|---|---|
Intraoperative enoxaparin minimizes inflammatory reaction after pediatric cataract surgery.
Topics: Acetates; Cataract; Cataract Extraction; Cell Count; Drug Combinations; Endothelium, Corneal; Enoxap | 2006 |
Low molecular-weight heparin in the intraocular irrigating solution in pediatric cataract and intraocular lens surgery.
Topics: Acetates; Cataract; Cataract Extraction; Drug Combinations; Endothelium, Corneal; Enoxaparin; Fibrin | 2006 |